SU2C Scientific Advisory Committee (SAC)
Phillip A. Sharp, PhD
Institute Professor; David H. Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Cambridge, Massachusetts
Elizabeth H. Blackburn, PhD
Morris Herzstein Professor of Biology and Physiology
University of California, San Francisco
San Francisco, California
Raymond N. DuBois, MD, PhD, FAACR
Professor and Dean
College of Medicine, Medical University of South Carolina
Charleston, South Carolina
Lee J. Helman, MD
Director of Cancer Research Program
Children’s Hospital Los Angeles; Professor of Pediatrics
Keck School of Medicine of University of Southern California
Los Angeles, California
Arnold J. Levine, PhD
Professor
Institute for Advanced Study and Cancer Institute of New Jersey
Princeton, New Jersey
William G. Nelson, MD, PhD
Director
Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University
Baltimore, Maryland
Edith A. Perez, MD
Chief Medical Officer, Bolt Biotherapeutics
Professor of Medicine, Mayo Clinic Chair
San Francisco, California
Carlos L. Arteaga, MD
Director and Associate Dean of
Oncology Programs
UT Southwestern Harold C. Simmons Cancer Center
Dallas, Texas
Alan Bernstein, PhD
President and CEO
Canadian Institute for Advanced Research (CIFAR)
Toronto, Ontario, Canada
Judy E. Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention
Dana-Faber Cancer Institute
Boston, Massachusetts
Richard B. Gaynor, MD
President of Research & Development
Neon Therapeutics
Indianapolis, Indiana
Nancy F. Goodman, JD
Founder and Executive Director
Kids v. Cancer
Washington, District of Columbia
William N. Hait, MD, PhD, FAACR
Global Head of External Innovation
Janssen, Pharmaceutical Companies of
Johnson & Johnson
Raritan, New Jersey
William G. Kaelin Jr., MD
Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts
Guillermina (Gigi) Lozano, PhD
Chairman and Professor, Department of Genetics
The University of Texas MD Anderson Cancer Center
Houston, Texas
Tak W. Mak, PhD
Chief Scientific Officer
Campbell Family Institute for Breast Cancer Research
Toronto, Ontario, Canada
Andre Nussenzweig, PhD
Chief, Laboratory of Genome Integrity
NIH Distinguished Investigator
Center for Cancer Research National Cancer Institute
Bethesda, Maryland
Roderic I. Pettigrew, PhD, MD
CEO of Engineering Health (EnHealth) and Executive Dean for Engineering Medicine (EnMed)
Texas A&M University
Houston, Texas
Arlene H. Sharpe, MD, PhD
George Fabyan Professor of Comparative Pathology
Co-Director, Harvard Institute of Translational Immunology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School
Boston, Massachusetts
Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research (Friends)
Washington, District of Columbia
David A. Tuveson MD, PhD
Chief Scientist of the Lustgarten Foundation
Director, Cold Spring Harbor Laboratory Cancer Center
Cold Spring Harbor, New York